SCHEMBL7002893

SCHEMBL7002893

CCN(CC)CCNC(=O)COc1cc[c]cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.73
CYP2D6 P10635 1/20 0.73
CYP3A4 P08684 1/20 0.71
ALDH1A1 P00352 3/20 0.44
TSHR P16473 2/20 0.44
KDM4E B2RXH2 1/20 0.44
RECQL P46063 1/20 0.44
RAB9A P51151 2/20 0.44
HDAC1 Q13547 1/20 0.44
CASP2 P42575 1/20 0.44
KMT2A Q03164 1/20 0.43
LMNA P02545 2/20 0.43
IGF1R P08069 1/20 0.43
NPC1 O15118 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
SLC22A2 O15244 1/20 0.43
SLC22A1 O15245 1/20 0.43
ACHE P22303 1/20 0.43
MAPK1 P28482 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7001422 0.85 CYP1A2 (0.54) CYP1A2CYP2D6CYP3A4ALDH1A1RECQL
Mefexamide SCHEMBL126334 0.84 CYP1A2 (1.00) CYP1A2CYP2D6CYP3A4ALDH1A1KDM4E
SCHEMBL7701481 0.84 CYP1A2 (0.63) CYP1A2CYP2D6CYP3A4ALDH1A1TSHR
SCHEMBL6611709 0.84 TSHR (0.52) CYP1A2CYP2D6CYP3A4ALDH1A1TSHR
Clofexamide SCHEMBL1604514 0.83 CYP1A2 (0.78) CYP1A2CYP2D6CYP3A4ALDH1A1KDM4E
Mefexamide SCHEMBL364170 0.83 CYP3A4 (1.00) CYP1A2CYP2D6CYP3A4ALDH1A1KDM4E
Mefexamide SCHEMBL1650022 0.82 CYP1A2 (0.95) CYP1A2CYP2D6CYP3A4ALDH1A1KDM4E
Clofexamide SCHEMBL365077 0.82 CYP3A4 (0.78) CYP1A2CYP2D6CYP3A4ALDH1A1KDM4E
SCHEMBL692842 0.81 SMN1; SMN2 (0.62) CYP1A2CYP2D6CYP3A4ALDH1A1TSHR
Hydrochloric Acid SCHEMBL11539142 0.79 CYP3A4 (0.73) CYP1A2CYP2D6CYP3A4KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1335836-A Tricyclic pyrazole derivatives BASF AG (DE) 2002-02-13 CN claimed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP claimed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO claimed
EP-1165544-B1 SUBSTITUTED 1,4-DIHYDROINDENO[1,2-C]PYRAZOLES AS INHIBITORS OF TYROSINE KINASE KNOLL GMBH (DE) 2003-08-06 EP disclosed
EP-1268437-A1 INHIBITORS OF PROTEIN KINASES Knoll GmbH (DE) 2003-01-02 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
CN-1368970-A Substituted 1,4-dihydroindeno [1,2-C] pyrazoles as inhibitors of tyrosine kinase KNOLL GMBH (DE) 2002-09-11 CN disclosed
WO-2002030908-A1 INHIBITORS OF PROTEIN KINASES KNOLL GMBH (DE) 2002-04-18 WO disclosed
CN-1335836-A Tricyclic pyrazole derivatives BASF AG (DE) 2002-02-13 CN disclosed
EP-1165544-A1 SUBSTITUTED 1,4-DIHYDROINDENO[1,2-C]PYRAZOLES AS INHIBITORS OF TYROSINE KINASE BASF AKTIENGESELLSCHAFT (DE) 2002-01-02 EP disclosed
US-6297238-B1 3-ARYL PYRAZOLES WITH 4,5(3,4)-BICYCLIC RING FUSION WHICH ARE INHIBITORS OF PROTEIN KINASES PARTICULARLY TYROSINE KINASES AND SERINE/THREONINE KINASES BASF AKTIENGESELLSCHAFT (DE) 2001-10-02 US disclosed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2000059901-A1 SUBSTITUTED 1,4-DIHYDROINDENO[1,2-C]PYRAZOLES AS INHIBITORS OF TYROSINE KINASE KNOLL GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2000-10-12 WO disclosed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed